Both in Pharmaceuticals
Turn Therapeutics vs Emergent Biosolutions
Over the past year TTRX returned +111.9% and EBS returned −26.8%; their daily moves had a correlation of 0.12.
TTRX +111.9% EBS −26.8%Growth of $1, one year, split-adjusted
| Metric | TTRX | EBS |
|---|---|---|
| Price | $11.13 | $6.93 |
| Market cap | $337.8M | $355.3M |
| Today | +6.77% | +3.90% |
| 1 month | −17.0% | +0.1% |
| 6 months | +212.9% | −13.3% |
| Year to date | +182.4% | −43.9% |
| 1 year | +123.8% | −28.5% |
| Revenue growth (YoY) | — | +66.3% |
| Gross margin | — | 58.6% |
| Net margin | — | −76.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.5× |
| Net cash | $4.2M | -$442.1M |
| Dividend yield | — | — |
| Volatility (60d) | 91.2% | 97.4% |
| Short % of float | 3.0% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).